201 studies found for:    "Osteoporosis, Postmenopausal"
Show Display Options
Rank Status Study
21 Completed Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Ibandronate (SB743830HD)
22 Completed ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
Condition: Post Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
23 Completed
Has Results
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice
Condition: Osteoporosis, Postmenopausal
Intervention: Biological: Denosumab
24 Completed SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
Condition: Post Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
25 Completed BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
26 Completed
Has Results
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Condition: Post Menopausal Osteoporosis
Interventions: Drug: Ibandronate [Bonviva/Boniva];   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D
27 Completed
Has Results
A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis
Condition: Post Menopausal Osteoporosis
Intervention: Drug: Ibandronate
28 Completed
Has Results
A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis
Condition: Post Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
29 Completed
Has Results
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
30 Completed
Has Results
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
31 Completed
Has Results
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Condition: Post Menopausal Osteoporosis
Interventions: Drug: Risedronate;   Drug: ibandronate [Bonviva/Boniva]
32 Completed Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: disodium clodronate 200 mg/4 ml with 1% lidocaine;   Drug: Disodium clodronate 100 mg/3,3 ml with 1% lidocaine
33 Completed Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Bazedoxifene;   Drug: Calcium/Vit D
34 Completed Radius Loading in Primary Hyperparathyroidism
Conditions: Primary Hyperparathyroidism;   Bone Diseases, Metabolic;   Osteoporosis, Postmenopausal;   Bone Loss, Postmenopausal
Interventions: Other: Forearm exercise program;   Other: Walking program
35 Completed Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Bazedoxifene;   Drug: Placebo
36 Completed Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
37 Active, not recruiting Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 785;   Drug: Placebo;   Drug: Denosumab
38 Completed Wellnara Post-marketing Surveillance in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2/LNG oral (Wellnara, BAY86-5029)
39 Completed Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate (HMR4003)
40 Unknown  Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Liuwei Dihuang Pills

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years